Cargando…
Neuronal Apoptosis and Motor Deficits in Mice with Genetic Inhibition of GSK-3 Are Fas-Dependent
Glycogen synthase kinase-3 (GSK-3) inhibitors have been postulated as useful therapeutic tools for the treatment of chronic neurodegenerative and neuropsychiatric diseases. Nevertheless the clinical use of these inhibitors has been limited by their common side effects. Lithium, a non-selective GSK-3...
Autores principales: | Gómez-Sintes, Raquel, Lucas, José J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734180/ https://www.ncbi.nlm.nih.gov/pubmed/23940673 http://dx.doi.org/10.1371/journal.pone.0070952 |
Ejemplares similares
-
GSK-3 Mouse Models to Study Neuronal Apoptosis and Neurodegeneration
por: Gómez-Sintes, Raquel, et al.
Publicado: (2011) -
The Fas/Fas Ligand Death Receptor Pathway Contributes to Phenylalanine-Induced Apoptosis in Cortical Neurons
por: Huang, Xiaodong, et al.
Publicado: (2013) -
Calreticulin Binds to Fas Ligand and Inhibits Neuronal Cell Apoptosis Induced by Ischemia-Reperfusion Injury
por: Chen, Beilei, et al.
Publicado: (2015) -
Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids
Publicado: (1995) -
REV-ERBα Agonist GSK4112 attenuates Fas-induced Acute Hepatic Damage in Mice
por: Shao, Ruyue, et al.
Publicado: (2021)